0000947871-12-000329.txt : 20120319 0000947871-12-000329.hdr.sgml : 20120319 20120319181605 ACCESSION NUMBER: 0000947871-12-000329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120315 FILED AS OF DATE: 20120319 DATE AS OF CHANGE: 20120319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DE LA TOUR DAUVERGNE LAURAGUAIS BERNARD P CENTRAL INDEX KEY: 0001284255 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16625 FILM NUMBER: 12701734 BUSINESS ADDRESS: STREET 1: BUNGE LTD STREET 2: 50 MAIN ST CITY: WHITE PLAINS STATE: NY ZIP: 10606 BUSINESS PHONE: 9146842800 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bunge LTD CENTRAL INDEX KEY: 0001144519 STANDARD INDUSTRIAL CLASSIFICATION: FATS & OILS [2070] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 MAIN STREET STREET 2: 6TH FLOOR CITY: WHITE PLAINS STATE: NY ZIP: 10606 BUSINESS PHONE: 914-684-2800 MAIL ADDRESS: STREET 1: 50 MAIN STREET STREET 2: 6TH FLOOR CITY: WHITE PLAINS STATE: NY ZIP: 10606 FORMER COMPANY: FORMER CONFORMED NAME: BUNGE LTD DATE OF NAME CHANGE: 20010710 4 1 ss140441_4-delatour.xml OWNERSHIP DOCUMENT X0304 4 2012-03-15 0 0001144519 Bunge LTD BG 0001284255 DE LA TOUR DAUVERGNE LAURAGUAIS BERNARD P C/O BUNGE LTD., 50 MAIN STREET 6TH FLOOR WHITE PLAINS, NY 10606 1 0 0 0 Common Stock 2012-03-15 4 S 0 2535 67.63 D 325298 D Common Stock 2012-03-15 4 M 0 7200 21.61 A 332498 D Common Stock 3 I Spouse Stock Option (right to buy) 21.61 2012-03-15 4 M 0 7200 0 D 2003-01-01 2012-05-24 Common Stock 7200 0 D All of the transactions reported on this Form 4 were effected pursuant to a written 10b5- l trading plan adopted in accordance with SEC Rule 10b5-1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.60 to $67.80, inclusive. The reporting person undertakes to provide to Bunge Ltd., any security holder of Bunge Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. /s/ John Tropeano, Attorney-in-Fact 2012-03-19